The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c02896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Zachary A Kasun und 19 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, California 94404, United States. Hauptthemen laut MEDLINE: Fructokinases, Enzyme Inhibitors, Amines, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Ketohexokinase (KHK) is the primary enzyme involved in fructose metabolism, converting fructose to fructose-1-phosphate (F1P). KHK is implicated in diseases, including metabolic-dysfunction-associated steatotic liver disease (MASLD) and diabetic kidney disease (DKD), among others. Herein, we describe the discovery of GS-1291269, a potent, neutral KHK inhibitor. GS-1291269 has pharmacokinetic parameters in preclinical species that support once-daily dosing in humans. The high potency and favorable PK profile of GS-1291269 can be attributed to the uncommon dioxo-thietane amine functional group, which avoids potential PK liabilities associated with acidic or basic molecules yet provides a hydrogen bond donor that is critical for potency. Furthermore, GS-1291269 demonstrated liver and kidney fructose-1-phosphate (F1P) reduction in a fructose challenge model in rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gilead Sciences, Inc., Foster City, California 94404, United States.
ORCID-Profile: Zachary A Kasun, Nathaniel H Stanley
Förderung
- Gilead Sciences
Zitieren
APA
Kasun, Z. A., Liang, X., Ferrao, R. D., Kaplan, J. A., Clark, C. T., Neubig, M. E., Byun, D. H., Badal, S. S., Sroda, N., Mistry, T., Stanley, N. H., Stevens, K. L., Bachman, J. L., Lo, J. R., Loyer-Drew, J., Velasquez, M., Hao, J., Mwangi, J., Stafford, B., & Jansa, P. (2025). The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02896
Vancouver
Kasun ZA, Liang X, Ferrao RD, Kaplan JA, Clark CT, Neubig ME, et al. The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02896
BibTeX
@article{Kasun2025,
author = {Kasun, Zachary A and Liang, Xiaomin and Ferrao, Ryan D and Kaplan, Joshua A and Clark, Christopher T and Neubig, Megan E and Byun, Daniel H and Badal, Shawn S and Sroda, Natalie and Mistry, Tina and Stanley, Nathaniel H and Stevens, Kirk L and Bachman, James L and Lo, Jennifer R and Loyer-Drew, Jennifer and Velasquez, Maile and Hao, Jia and Mwangi, Judy and Stafford, Brian and Jansa, Petr},
title = {The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c02896}
}
EUVIMED